Episode Details
Back to Episodes354: Uncertainty in CRISPR world and the start of more M&A
Published 1 year, 5 months ago
Description
We chat about M&A deals picking up, leadership changes at Novo, and recent FDA advisory committee meetings for cancer drugs. We also bring on STAT reporter Jason Mast to talk about the latest research and sentiment at the annual American Society of Cell and Gene Therapy meeting.